Dr. Lal PathLabs Ltd
NSE:LALPATHLAB

Watchlist Manager
Dr. Lal PathLabs Ltd Logo
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
Watchlist
Price: 1 391.6 INR -0.37% Market Closed
Market Cap: 116.2B INR

Net Margin
Dr. Lal PathLabs Ltd

20.6%
Current
16%
Average
1.8%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
20.6%
=
Net Income
5.3B
/
Revenue
26B

Net Margin Across Competitors

No Stocks Found

Dr. Lal PathLabs Ltd
Glance View

Market Cap
116.2B INR
Industry
Health Care

Dr. Lal PathLabs Ltd. traces its origins back to 1949 when Dr. S.K. Lal, a committed professional with a vision for transforming patient care in India, laid its foundation. With a single laboratory in Delhi, the firm embarked on a journey to make diagnostic services accessible, accurate, and affordable for millions. Over the years, the company's dedication to eking out a niche in the healthcare sector was epitomized by its expansive network that bridges urban and rural India. As of today, it boasts a robust footprint with thousands of patient service centers and diagnostic facilities, enabling them to deliver high-quality pathology services across the length and breadth of the country. This network is instrumental in addressing the diagnostic needs of individuals, bringing specialized tests and healthcare packages within arm's reach of the populace, thus weaving healthcare into the fabric of everyday life. Financially, Dr. Lal PathLabs Ltd. thrives on a well-oiled operational model that deftly balances reach, scalability, and innovation. The company's revenue streams are predominantly anchored in routine and specialized pathology tests, ranging from basic blood tests to complex genetic analyses. By deploying state-of-the-art technology and adhering to high standards of quality control, the firm ensures precision, which instills trust and sustains its business growth. Additionally, strategic collaborations with hospitals, corporate health programs, and wellness initiatives further bolster its financial health. This integrative approach, coupled with a commitment to swallowing costs through operational efficiencies, allows Dr. Lal PathLabs to maintain competitive pricing strategies, thus ensuring sustainable profitability while continuing to innovate in the face of an ever-evolving healthcare landscape.

LALPATHLAB Intrinsic Value
2 065.52 INR
Undervaluation 33%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
20.6%
=
Net Income
5.3B
/
Revenue
26B
What is the Net Margin of Dr. Lal PathLabs Ltd?

Based on Dr. Lal PathLabs Ltd's most recent financial statements, the company has Net Margin of 20.6%.

Back to Top